Seminar on breast pathology in AMU
ALIGARH: Interactive sessions and engaging discussions on advances in breast cancer research and various aspects of endocrine disorders marked the inaugural function of the twoday symposium and slide seminar on ‘Breast Pathology and Updates in Endocrine Pathology’ that began in the department of pathology, Jawaharlal Nehru Medical College (JNMC), Aligarh Muslim University (AMU) on Wednesday .
“Breast pathology is a challenging area involved in diagnostic surgical pathology and pathologists play a key role in the multidisciplinary care team of patients with endocrine diseases”, said AMU vice chancellor, Prof Tariq Mansoor.
Attending the inaugural function as the chief guest, he stressed: “In times to come, endocrine pathology will demand an in-depth understanding of structure, function, prognosis and prediction and it is anticipated that new technologies will allow increased sub specialization in pathology and growth of this important area of expertise”. The resource person, Prof Ashraf Khan (department of pathology, UMASS Chan Medical School, Baystate, Springfield MA, USA and Adjunct Faculty, department of pathology, JNMC) provided updates on predictive biomarkers in breast cancer and adrenals. He spoke about challenges in the assessment of the main breast cancer-specific molecular predictive markers such as hormone receptors, progesterone receptors and human epidermal growth factor receptors among others.
Prof Nuzhat Husain (head, department of pathology, Dr Ram Manohar Lohia Institute of Medical Sciences, Lucknow) who also attended the programme as the resource person, gave WHO updates on pituitary problems. “The new WHO classification of tumors of endocrine organs, includes innovations in both terminology and diagnostic guidelines for pituitary adenomas, along with new entities, molecular information, and novel treatment modalities”, she said. Prof M U Rabbani (dean, faculty of medicine) emphasised: “The job of a pathologist as a diagnostic oncologist encompasses the entire spectrum of cancer care from prevention and screening to diagnosis, prognosis, and prediction of therapeutic response.”